79 related articles for article (PubMed ID: 22519213)
1. [Preliminary results of effectiveness of two schemes of controlled ovarian hyperstimulation protocols with recombinant foliculle stimulating hormone in intrauterine insemination cycles].
Barros Delgadillo JC; Fiszman Amora R; Santibañez Morales A; Sánchez Solis V; Gaviño Gaviño F
Ginecol Obstet Mex; 2012 Feb; 80(2):61-72. PubMed ID: 22519213
[TBL] [Abstract][Full Text] [Related]
2. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.
Casadei L; Zamaro V; Calcagni M; Ticconi C; Dorrucci M; Piccione E
Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):155-61. PubMed ID: 16687201
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
Demirol A; Gurgan T
Hum Reprod; 2007 Jan; 22(1):97-100. PubMed ID: 16954409
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
[TBL] [Abstract][Full Text] [Related]
5. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
Kabli N; Sylvestre C; Tulandi T; Buckett W
Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
[TBL] [Abstract][Full Text] [Related]
6. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial.
Berker B; Kahraman K; Taskin S; Sukur YE; Sonmezer M; Atabekoglu CS
Arch Gynecol Obstet; 2011 Dec; 284(6):1561-6. PubMed ID: 21773781
[TBL] [Abstract][Full Text] [Related]
7. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
[TBL] [Abstract][Full Text] [Related]
8. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
Tarlatzis BC; Griesinger G; Leader A; Rombauts L; Ijzerman-Boon PC; Mannaerts BM
Reprod Biomed Online; 2012 Apr; 24(4):410-9. PubMed ID: 22386594
[TBL] [Abstract][Full Text] [Related]
9. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
[TBL] [Abstract][Full Text] [Related]
11. [Differing response to GnRH antagonists in cycles of ovarian hyperstimulation plus intrauterine insemination].
Barros-Delgadillo JC; Trejo-Castañeda H; E-Ormsby C; Gaviño-Gaviño F
Ginecol Obstet Mex; 2010 Jan; 78(1):15-28. PubMed ID: 20931799
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
[TBL] [Abstract][Full Text] [Related]
13. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.
Kocak M; Dilbaz B; Demir B; Taşci Y; Tarcan A; Dede S; Haberal A
Gynecol Endocrinol; 2010 Jun; 26(6):429-34. PubMed ID: 20175705
[TBL] [Abstract][Full Text] [Related]
14. Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?
Caserta D; Lisi F; Marci R; Ciardo F; Fazi A; Lisi R; Moscarini M
Gynecol Endocrinol; 2011 Nov; 27(11):862-6. PubMed ID: 21391759
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
[TBL] [Abstract][Full Text] [Related]
16. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
Erdem A; Erdem M; Atmaca S; Guler I
Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
[TBL] [Abstract][Full Text] [Related]
17. Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study.
Isaza V; Requena A; García-Velasco JA; Remohí J; Pellicer A; Simón C
J Reprod Med; 2003 Feb; 48(2):112-8. PubMed ID: 12621795
[TBL] [Abstract][Full Text] [Related]
18. Further considerations on natural or mild hyperstimulation cycles for intrauterine insemination treatment: effects on pregnancy and multiple pregnancy rates.
Goverde AJ; Lambalk CB; McDonnell J; Schats R; Homburg R; Vermeiden JP
Hum Reprod; 2005 Nov; 20(11):3141-6. PubMed ID: 16037113
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
[TBL] [Abstract][Full Text] [Related]
20. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
